Prediction of Physiological Status of Sickle Cell Anemic Patients by Quantitative Observations of Microscopic Components of Urine
In the present study, some cellular and crystalline components of urine of Sickle Cell Anemia (SCA) were studied. In total 67 samples were investigated. The normal and abnormal cellular components like presence of Red blood cells, White blood cells Epithelial cells, Renal tubules cells, Bacteria, Yeast and Protozoan were observed and counted. Noncellular components/crystals like Tyrosine, Cholesterol, A/T Phosphate, Leucine, B-Granule, Uric Acid, Oxalate and Cystine were counted. It was observed that RBCs, WBCs and Epithelial cells, Renal tubules cells, Bacteria, Yeast and Protozoan were in high number indicating various complications occurring in the body of sickle cell anemic patients. It was observed that RBCs were 13918.18/cumm±SE 4057.90 indicating tremendous hematourea, number of WBC were 224.59±50.002 SE, Sqaumous Epithelial cells were 35.68±10.989 SE, Renal cells were 110.68±74.15 SE. This indicates that SCA patients suffer from kidney damage, hematourea, Urinary Tract Inflammation, Interstitial nephritis, Glomerulonephritis and Pylonephritis.
to cite this article:
Varsha Wankhade, R.B. Andhale and Sangita Lodha, 2013. Prediction of Physiological Status of Sickle Cell Anemic Patients by Quantitative Observations of Microscopic Components of Urine. Trends in Medical Research, 8: 27-31.
Received: December 12, 2012;
Accepted: April 15, 2013;
Published: June 17, 2013
Sickle Cell Disease (SCD) is one of the common genetic disorders affecting
large population of the world. In sickle cell anemia RBCs become sickle shaped
due to presence of abnormal Hemoglobin (HbS). SCD patients need regular blood
transfusion. Based on the World Health Organization published global prevalence
map of SCD and other data, it was estimated that about 20-25 million individuals
worldwide have homozygous SCD; 12-15 million in sub-Saharan Africa, 5-10 million
in India and about 3 million distributed in different parts of the world (Serjeant,
2006). It is estimated that each year over 300,000 babies with severe form
of sickle cell disease are born worldwide. The majority of which is the middle
and low income countries. About 5% of the population of world is carrier of
gene for sickle cell disease, this percentage may vary and may be high up to
25% in some countries. A high concentration of the disease is in Asia, the Mediterranean
basis, the Middle East and the Africa (http://www.who.int/genomics/public/Maphaemoglobin.pdf).
Reports said that 10-30% tribal population of central India are affected by
SCD. There may be 500000 and 1,000,000 cases of SCD in India (Adams
et al., 1998; Alexy et al., 2005,
A variety of renal abnormalities have found to be associated with sickle cell
(SS) disease (McCoy, 1969; Schlitt
and Keitel, 1960; Sweeney et al., 1962).
One of the common causes of death in adults from sickle cell disease are reported
due to renal failure (Darbari et al., 2006).
Kidney damage begins very early and progresses throughout life (Rossi-Espagnet
et al., 1968; Eckman and Platt, 1991; Saborio
and Scheinman, 1999).
Microscopic examination of urine is the cheapest and the easiest technique
to determine the physiology of the kidney. By investigating urines
components one can know the metabolic disturbances going on inside the various
systems of the body. The objective of the present study was to know whether
the quantitative analysis of urine of SCD generates information regarding the
pathophysiological status of SCD. The purpose of the present study was to perform
the quantitative analysis of normal and abnormal microscopic components of the
urine samples of sickle cell anemic patients and correlate its association with
the physiologic status of kidney in SCD. For this study we have selected the
sickle cell population of district Amravati, Maharashtra, India. In the present
study some cellular and crystalline components of urine of SCA were observed
MATERIALS AND METHODS
Study population: The study population consisted of 67 randomized Sickle
cell diseased populations from district Amravati, Maharashtra, India. This study
was approved by Institutional Human Ethics Committee. Written consent from each
participant was taken.
Collection of sample: A clean catch urine sample was obtained. Urine
sample was collected from the participants by the standard spontaneous voiding
procedure as stated by Corwin (1996). Urine was collected
at about noon to avoid contamination of urine by contents of urethra or vagina
and therefore its constituents are more likely to reflect kidney origin. First
void sample was also collected, because this is usually, a concentrated specimen
and most informative. Urine was collected in a sterile, labeled bottle containing
4% formaldehyde. Urine was transported to the laboratory immediately in an ice
bag. All the analysis were performed within a week (European
Confederation of Laboratory Medicine, 2000; Skobe, 2004).
Preparation of urine sample: Ten milliliter of urine was centrifuged
at 2,000 rpm for 5 min. Following aspiration of the supernatant to a marked
level, the pellet was agitated into a homogeneous mixture followed by a sampling
pipette provided by the manufacturer (Tarson). This was followed by microscopic
analysis of urine using Magnus inclined trinocular microscope (Make-Olympus).
Microscopic analysis of urine: A drop of prepared urine sample was pipetted
onto a Neubars chamber slide and a coverslip was placed. The slide was then
examined. The urine sediment is routinely examined by bright field microscopy
under both low and high power without staining. For the present study, prepared
slide was observed under the Magnus inclined trinocular microscope (Make-Olympus).
After that, RBCs, WBCs and ECs were examined using a High-power Field (HPF)
and were counted.
The normal and abnormal cellular components like of RBCs, WBCs, Epithelial
cells, Renal tubules cells, Bacteria, Yeast and Protozoan were counted and noted.
Non-cellular components like Tyrosine, Cholesterol, A/T Phosphate, Leucine,
B-Granule, Hyaline, Uric Acid, Oxalate and Cystine were also counted.
RESULTS AND DISCUSSION
Quantitative study of normal and abnormal cellular components and crystalline
components of urine such as RBCs, WBCs, Epithelial cells, Renal tubules cells,
Bacteria, Yeast and Protozoan was performed.
We observed that the number of cellular and crystalline component of urine
is very high. It was observed that mean value of number of RBCs were 13918.18,
WBCs were 224.59, Sqaumous Epithelial cells were 35.68182, Renal Cells were
110.6818 and Cholesterol were 11 per cumm. This indicates various complications
in the kidney of sickle cell anemia. Quantitative analysis of Cellular and crystalline
components of urine of SCA is shown in Table 1.
Crystalline components of urine in SCA: Non-cellular components like
Tyrosine, Cholesterol, A/T Phosphate, Leucine, B-Granule, Hyaline, Uric Acid,
Oxalate, Cystine were also counted in the urine sample of sickle cell anemic
patients. The mean value of number of some crystals were very high in the urine.
Uric acid crystals were 9.77, triple phosphate were 36.13, Tyrosine crystal
56.81, Casts were 21.36, Calcium oxalate were 256.13 and calcium carbonate were
79.54 per cumm area.
Microscopic analysis can help distinguish patients with Urinary Tract Infection
or renal disease. In the present microscopic investigation on urine of SCD,
we observed RBCs in high number indicating hematuria, may be because of the
Glomerulonephritis, vasculitis and inflammation. White blood cells were also
more in number which may appear in the urine in Interstial nephritis and pylonephritis.
Epithelial cells are observed due to Acute tubular necrosis, interstitial nephritis
and glomerulonephritis. Renal tubular cells were found due to renal tubular
damage (Oser, 1976). Non-cellular/crystalline components
in urine of SCD also express various abnormal conditions. Presence of large
number of Uric acid, tyrosine, oxalate, A/T Phosphate, Hyaline etc. is the indication
of acute nephropathy. Appearance of high cholesterol in urine indicates heavy
protein urea due to improper filtration at Glomerulus (Oser,
1976). Presence of Cystine in the urine of SCD indicates the abnormal metabolic
process in the body (Oser, 1976). On the basis of microscopic
analysis of urine of SCA it could be concluded that the Kidney of such patients
are under risk and suffering from various complications like nephrites, glomerular
damage, hematourea etc.
|| Quantitative analysis of microscopic components of urine
of sickle cell anemic patients
On the basis of cellular and non-cellular components of urine of SCA patients,
probable physiological complications going on inside the important organs like
kidney, liver, urinary bladder ect could be predicted. It was found that SCA
patients suffered by various complications. Present study indicates that 69.7%
patients of SCA suffers from Cystisis and Urinary Tract Inflammation, 96.9%
patients suffer from Interstitial nephritis, Acute Tubular Necrosis and Glomerulonephritis.
66.7% SCA patients suffer from Pylonephritis which means inflammation of renal
pelvis. 16% SCA patients suffer from Chyluria. In 15% SCA patients Atrophy and
Cirrosis of liver could be seen while 53% patients suffers from liver dysfunction.
The renal concentrating defect in sickle cell anemia is apparently related
to polymerization of sickle hemoglobin in the hyperosmolar renal medulla, which
increases the concentration of hemoglobin within red cells. The ultimate result
is almost complete destruction of the vasa recta and particularly disruption
of the juxta medullary nephrons with long loops of Henle extending into the
intramedullary zone (Miller et al., 2011),which
results in an inability to super-concentrate urine in the presence of water
deprivation (Van Eps et al., 1970). Studies
examining the prevalence and severity of the renal concentrating defect in sickle
cell disease were largely done in the 1950s by Kunz et
al. (1954). Renal failure in SCD varies from 5-18% (Scheinman,
1994). Powars et al. (1991) reported 4.2%
SCD patients affected with renal failure. Platt et al.
(1994) observed 18% overall mortality in adult SCD patients with 40% of
these due to renal failure. Renal thrombosis and intravascular hemolysis could
be one cause of acute and renal insufficiency in SCD patients (Sklar
et al., 1990). However, the renal abnormalities start at earlier
ages (Tejani et al., 1985).
Quantitative study of Microscopic components of urine of SCD of district Amravati,
MS, India exhibits high number of RBCs, WBCs, Sqaumous epithelial cells, renal
tubular cells ect. Urine of the sickle cell anemic patients also shows high
number of crystalline components in the urine. Present study shows that the
SCA patients at district Amravati are under the threat of Glomerulonephritis,
urinary tract infection, urinary tract inflammation, tubular necrosis, Interstitial
nephritis, Pylonephritis etc. Thus we can conclude that the kidney of the SCA
is in high risk, hence proper and timely precautions should be taken to lessen
the damage to this important organ. SCA should be managed properly as soon as
it is detected so that the vital organs could be protected and saved from deterioration.
The authors are grateful to Board of College and University Development, University
of Pune for financial support. First author is thankful to Centre for advanced
studies and DST-PURSE for partial financial support. We are thankful to Thalassemia
Center, Jankalyan Blood Bank, Nashik and Mr.Narendra Manwar, Department of Zoology,
University of Pune for their co-operation throughout the research work.
Adams, R.J., V.C. McKie, L. Hsu, B. Files and E. Vichinsky et al
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med., 39: 5-11.CrossRef | PubMed |
Alexy, T., R.B. Wenby, E. Pais, L.J. Goldstein, W. Hogenauer and H.J. Meiselman, 2005.
An automated tube-type blood viscometer: Validation studies. Biorheology, 42: 237-247.PubMed |
Alexy, T, E. Pais, J.K. Armstrong, H.J. Meiselman, C.S. Johnson and T.C. Fisher, 2006.
Rheologic behaviour of sickle and normal red blood cell mixtures in sickle plasma: Implications for transfusion therapy. Transfusion, 46: 912-918.CrossRef | PubMed |
Corwin, H.L., 1996.
Urinalysis in Diseases of the Kidney. 6th Edn., Boston Little Brown and Company, USA., pp: 295-306
Darbari, D.S., P. Kple-Faget, J. Kwagyan, S. Rana, V.R. Gordeuk and O. Castro, 2006.
Circumstances of death in adult sickle cell disease patients. Am. J. Hematol., 81: 858-863.CrossRef | Direct Link |
Eckman, J.R. and A.F. Platt, 1991.
Problem Oriented Management of Sickle Syndromes. Grady Memorial Hospital, Atlanta, GA., USA., Pages: 143
Kunz, H.W., E.L. Pratt, G.W. Mellin and M.W. Cheung, 1954.
Impairment of urinary concentration in sickle cell anemia. Pediatrics, 13: 352-356.PubMed |
McCoy, R.C., 1969.
Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab. Invest., 21: 85-95.PubMed |
Miller, S.T., W.C. Wang, R. Iyer, S. Rana and P. Lane et al
Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG). Pediatr. Blood Cancer, 54: 265-268.CrossRef | PubMed |
Oser, B.L., 1976.
Hawk's Physiological Chemistry. 14th Edn., Tata McGraw-Hill Publishing Company Ltd., USA., pp: 1206-1281
Platt, O.S., D.J. Brambilla, W.F. Rosse, P.F. Milner, O. Castro, M.H. Steinberg and P.P. Klug, 1994.
Mortality in sickle cell disease-Life expectancy and risk factors for early death. N. Engl. J. Med., 330: 1639-1644.Direct Link |
Powars, D.R., D.D. Elliott-Mills, L. Chan, J. Niland, A.L. Hiti, L.M. Opas and C. Johnson, 1991.
Chronic renal failure in sickle cell disease: Risk factors, clinical course and mortality. Ann. Internal Med., 115: 614-620.CrossRef | PubMed |
Rossi-Espagnet, A., K.W. Newell, R. Maclennan, J.B. Mathison and S.P.H. Mandel, 1968.
The relationship of sickle cell trait to variations in blood pressure. Am. J. Epidemiol., 88: 33-44.PubMed | Direct Link |
Saborio, P. and J.I. Scheinman, 1999.
Sickle cell nephropathy. J. Am. Soc. Nephrol., 10: 187-192.Direct Link |
European Confederation of Laboratory Medicine, 2000.
European urinalysis guidelines. Scand. J. Clin. Lab. Invest. Suppl., 231: 1-86.PubMed | Direct Link |
Schlitt, L.E. and H.G. Keitel, 1960.
Renal manifestations of sickle cell disease: A review. Am. J. Med. Sci., 152: 773-778.PubMed | Direct Link |
Scheinman, J.I., 1994.
Sickle Cell Nephropathy. In: Pediatric Nephrology, Holliday, M., T.M. Barratt and E.D. Avner (Eds.). Williams and Wilkins, Baltimore, Maryland, pp: 908-919
Serjeant, G.R., 2006.
The case for dedicated sickle cell centres. Indian J. Hum. Genet., 12: 148-151.CrossRef | Direct Link |
Sklar, A.H., J.C. Perez, R.J. Harp and R.J. Caruana, 1990.
Acute renal failure in sickle cell anemia. Int. J. Artif. Organs, 13: 347-351.PubMed |
Skobe, C., 2004.
The basics of specimen collection and handling of urine testing. LabNotes, Vol. 14, No. 2.Direct Link |
Van Eps, L.W.S., C. Pinedo-Veels, G.H. de Vries and J. de Koning, 1970.
Nature of concentrating defect in sicklecell nephropathy: Microradioangiographic studies. Lancet, 1: 450-452.CrossRef | PubMed |
Sweeney, M.F., W.T. Dobbins and J.N. Etteldorf, 1962.
Renal disease with elements of the nephrotic syndrome associated with sickle cell anemia. J. Pediatrics, 60: 42-51.Direct Link |
Tejani, A., K. Phadke, O. Adamson, A. Nicastri, C.K. Chen and D. Sen, 1985.
Renal lesions in sickle cell nephropathy in children. Nephron, 39: 352-355.PubMed |